Compass Therapeutics, Inc.

CMPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 13, 2024 FORM 8-K
ARS Apr 29, 2024 ARS
DEFA14A Apr 29, 2024 DEFA14A
DEF 14A Apr 29, 2024 DEF 14A
8-K Apr 25, 2024 FORM 8-K
SC 13D/A Mar 22, 2024 AMENDMENT NO. 4
10-K Mar 21, 2024 FORM 10-K
8-K Mar 21, 2024 FORM 8-K
4 Mar 11, 2024
4 Feb 14, 2024
4 Feb 14, 2024
4 Feb 14, 2024
4 Feb 14, 2024
4 Feb 14, 2024
4 Feb 9, 2024
4 Feb 9, 2024
SC 13G/A Feb 9, 2024
SC 13G/A Feb 7, 2024 COMPASS THERAPEUTICS, INC.
SC 13G Feb 1, 2024 JANUS HENDERSON GROUP PLC OWNS 6.00% OF COMPASS THERAPEUTICS, INC.
4 Jan 10, 2024
4 Jan 10, 2024
8-K Jan 9, 2024 FORM 8-K
8-K Jan 5, 2024 FORM 8-K
SC 13G Nov 27, 2023 COMPASS THERAPEUTICS, INC.
4 Nov 21, 2023
← Newer Page 6 of 15 · 359 filings Older →